EICHOR
● Active Not Recruiting
A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
Condition: Atypical Hemolytic Uremic Syndrome · Sponsor: Hoffmann-La Roche
About this study
This study aims to evaluate the efficacy and safety of crovalimab in adult and adolescent participants with aHUS.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (42)
| Univ of CA San Francisco | San Francisco, California, United States | — |
| Children's Hospital Colorado | Aurora, Colorado, United States | — |
| Emory Children's Center | Atlanta, Georgia, United States | — |
| Washington University | St Louis, Missouri, United States | — |
| The Ohio State University Wexner Medical Center | Columbus, Ohio, United States | — |
| UT Health Science Center | San Antonio, Texas, United States | — |
| UZ Leuven Gasthuisberg | Leuven, Belgium | — |
| Santa Casa de Misericordia | Belo Horizonte, Minas Gerais, Brazil | — |
| UPECLIN Hospital das Clinicas da Faculdade de Medicina de Botucatu | Botucatu, São Paulo, Brazil | — |
| Hospital das Clinicas - FMUSP | São Paulo, São Paulo, Brazil | — |
| Vancouver General Hospital | Vancouver, British Columbia, Canada | — |
| Peking University First Hospital | Beijing, China | — |
+ 30 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04861259